CytoDyn settles Amarex lawsuit for $12M cash payment and $14M liability elimination

CytoDyn Inc.

Amarex to pay CytoDyn $12 million total, with $10 million received upon execution.
Surety bond of $6.5 million released and cash collateral returned to CytoDyn.
CytoDyn's $14 million accounts payable to Amarex eliminated at no cost.
Mutual release of all claims ends litigation filed in October 2021.
CEO cites improved balance sheet and ability to advance leronlimab trials.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.